Phase III Open-Label Randomized Study of Eribulin Mesylate Versus Capecitabine in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane

Kaufman, PA, Awada, A, Twelves, C et al. (7 more authors) (2015) Phase III Open-Label Randomized Study of Eribulin Mesylate Versus Capecitabine in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane. Journal of Clinical Oncology, 33 (6). pp. 594-601. ISSN 0732-183X

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: (c) 2015, American Society of Clinical Oncology. Creative Commons Attribution Non-Commercial No Derivatives 3.0 License [https://creativecommons.org/licenses/by-nc-nd/3.0/us/].
Dates:
  • Published: 20 February 2015
  • Published (online): 20 January 2015
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Cancer and Pathology (LICAP)
Depositing User: Symplectic Publications
Date Deposited: 06 Sep 2017 10:28
Last Modified: 06 Sep 2017 10:38
Status: Published
Publisher: American Society of Clinical Oncology
Identification Number: https://doi.org/10.1200/JCO.2013.52.4892
Related URLs:

Share / Export

Statistics